Viatris Inc. is a global healthcare company that develops, manufactures, and markets a broad portfolio of branded and generic pharmaceutical products. It specializes in generics, including commoditize... Viatris Inc. is a global healthcare company that develops, manufactures, and markets a broad portfolio of branded and generic pharmaceutical products. It specializes in generics, including commoditized and complex varieties as well as biosimilars, alongside legacy branded medicines such as Lipitor, Norvasc, Lyrica, and Viagra. The company addresses multiple therapeutic areas, including cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare, with particular focus on dermatology, ophthalmology, and gastroenterology. Viatris Inc. serves patients in over 165 countries through its extensive product offerings in the specialty and generic drug sectors. Founded in 2019 and headquartered in Canonsburg, Pennsylvania, it operates as one of the largest generic drug manufacturers worldwide, providing essential medicines and treatments to diverse healthcare markets.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Viatris is not subject to EU Taxonomy reporting

Based on current regulatory requirements, Viatris is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review Viatris's data?

Start your 30-day free trial to request a data review for Viatris.

Start Free Trial

Legal Center Contact Us